FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067699 [Registered on: 21/05/2024] Trial Registered Prospectively
Last Modified On: 18/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Other 
Public Title of Study   Peenisa chooranam for mookadaippu 
Scientific Title of Study   Single centric non Randomized open clinical Trial Phase II In Azhal thalainokkadu Sinusitis with Siddha Medicine Peenisa Chooranam among patients attending opd at Government Siddha medical college Hospital Chennai 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  R Sujatha 
Designation  PG Scholar 
Affiliation  Government Siddha Medical College Chennai 
Address  Post Graduate Department of Pothu Maruthuvam Government Siddha Medical College Arumbakkam Chennai

Chennai
TAMIL NADU
600106
India 
Phone  7550168344  
Fax    
Email  sujatha.srinivasan22384@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr G Ujjeevanam 
Designation  Professor 
Affiliation  Government Siddha Medical College Chennai 
Address  Department of Pothu Maruthuvam Government Siddha Medical College Arumbakkam Chennai

Chennai
TAMIL NADU
600106
India 
Phone  9884175653  
Fax    
Email  ujjeevanam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr G Ujjeevanam 
Designation  Professor 
Affiliation  Government Siddha Medical College Chennai 
Address  Department of Pothu Maruthuvam Government Siddha Medical College Arumbakkam Chennai

Chennai
TAMIL NADU
600106
India 
Phone  9884175653  
Fax    
Email  ujjeevanam@gmail.com  
 
Source of Monetary or Material Support  
Goverment Siddha Medical College Arumbakkam Chennai -600106 Tamilnadu ,India 
 
Primary Sponsor  
Name  R Sujatha 
Address  Post Graduate Department of Pothu Maruthuvam Government Siddha Medical College Arumbakkam Chennai 600106 Tamil nadu India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr R Sujatha  Government Siddha Medical College  Room No S1 Department of PG Pothu Maruthuvam Arumbakkam Chennai
Chennai
TAMIL NADU 
7550168344

sujatha.srinivasan22384@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, government siddha medical College, chennai   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J019||Acute sinusitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Peenisa Chooranam  This Siddha Drug will be given as 1.5 gm bd dose with luke warm water for 28 Days for the management of Sinusitis 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 All gender
2 Rhinorrhea
3 Nasal congestion
4 Pain and tenderness over paranasal sinus
5 Headache 
 
ExclusionCriteria 
Details  1 Septal deviation
2 Fungal sinusitis
3 Opthalmic headache
4 Trigeminal neuralgia
5 Sinus polyposis
6 Migraine
7 Otitis media
8 Vasomotor rhinitis
9 Pregnant and Lactating mother 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Dates of Birth or day of the Week 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The outcome of the treatment will be mainly assessed by reduction in clinical symptoms such as nasal obstruction,rhinitis,Post nasal drip,head ache ,facial pain.  4weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in clinical symptoms like nasal obstruction rhinorrhea post nasal drip headache  28 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   09/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  Nil

  6. For how long will this data be available start date provided 02-06-2025 and end date provided 31-12-2026?
    Response (Others) -  Nil

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   Sinuses are four paired cavities inside the head. narrow passages connect them. sinuses make mucus that drains out of the passages through nose. this drainage helps keep the nose clean and free of bacteria, allergens and other germs. sinusitis is an inflammation, or swelling, of the tissue lining of sinuses. Sinuses are structures inside the face that are normally filled with air. bacterial infections, viral infections and allergies can irritate them. causing them to get blocked and filled with fluid. it can cause pressure and pain in the face, nasal congestion and other symptoms. symptoms include nasal inflammation, thick discolored discharge from the nose, drainage down the back of the throat, nasal obstruction or congestion, pain, tenderness and swelling around the eyes, cheeks, nose or forehead, reduced sense of smell and taste, ear pain aching in upper jaw and teeth and cough.
Types of sinusitis can be defined based on how long it’s been going on and what’s causing it. acute sinusitis symptoms last less than four weeks. Subacute sinusitis symptoms last from to 12 weeks. chronic sinusitis symptoms last at least for 12 weeks. recurrent acute sinusitis symptoms come back four or more times in one year last less than two weeks each time.
In Siddha system of medicine, there are many unique combinations of medicines which have solution to the scenario of "AZHAL THALAINOKKADU"(SINUSITIS). one such combination is PEENISA CHOORANAM which will be cost effective and reliable.
so, it is considered to evaluate the siddha herbal formulation PEENISA CHOORANAM mentioned in DHANVANDHRI SOOTCHAMA VAITHIYAM 200 VISHA BEDHI VAITHIYAM page no 36 for the treatment of " AZHAL THALAINOKKADU"(SINUSITIS). the therapeutic efficacy of this Siddha formulation is so for not evaluated clinically for this disease.so the author tries to evaluate its efficacy in an open clinical trial. 

 
Close